Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
US FDA Observation
52 week high
|
Turnaround Potential
1311.9000
7.10
(
0.54
%)
NSE
Mar 12, 2026
15:31 PM
New 52W High today
Volume:
2.1M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
13 Aug 2024, 12:00AM
US FDA Observation
52 week high
1311.90
0.54%
Aurobindo Pharma Limited
Buy:
Aurobindo Pharma Ltd.
by
ICICI Direct
Target: 1785
Target
ICICI Direct
Aurobindo Pharma Ltd. is trading above all available SMAs
More from Aurobindo Pharma Ltd.
All Rapid Results
Recommended
India’s solar boom runs ahead of the grid
The Baseline |
12 Mar 2026, 05:06PM
Market closes lower on rising crude oil prices and tariff concerns
Trendlyne Marketwatch |
12 Mar 2026, 03:54PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020